Project 5 Frascati-mediated Mitochondrial Metabolism, Barry Paw
项目 5 弗拉斯卡蒂介导的线粒体代谢,Barry Paw
基本信息
- 批准号:9924635
- 负责人:
- 金额:$ 33.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY
The overall objective of this proposal is to identify and characterize novel proteins involved in erythroid
iron/heme metabolism. Erythropoiesis is a massive exercise in cellular proliferation and synthesis of a single
protein, hemoglobin. As a consequence, there is a tremendous demand for iron and heme to be efficiently
trafficked within the developing erythron. Despite advances in our understanding of extra-cellular iron
trafficking and proto-porphyrin biosynthesis, significant gaps remain, especially with respect to components
involving the egress of iron from the endosomes to the mitochondria, the trafficking of iron/heme within the
mitochondria, the transporters required for proto-porphyrin genesis, the cofactors that facilitate the intracellular
trafficking of iron/heme, and the eventual export of heme from the mitochondria for its incorporation in
hemoglobin. Using complementary approaches of genetics and bioinformatics from transcriptional profiling, we
previously identified several proteins, such as Mitoferrin1 (Mfrn1), Sorting Nexin3 (Snx3), Tmem14c, Lat3, and
Clpx1, as new components in the intracellular trafficking of iron, heme and nutrients crucial to red cell
development. Although transcriptional profiling as provided insights, we showed that post-translational
mechanisms play equally critical roles in the expression and function of proteins involved in iron and heme
metabolism. Using quantitative mass spectrometry, we examined changes in the mitochondrial proteome as
erythroid cells undergo maturation. We identified several solute carriers and transmembrane proteins, whose
function in erythropoiesis have not been previously ascribed, that were induced with hemoglobinization. We
propose to study the expression and loss-of-function phenotype of these 7 candidate genes (Aim 1). In
particular, we plan to focus previously identified gene, Fam210b (c20orf108), and its interacting partners in red
cell development (Aim 2). Functional elucidation of these structural genes will expand our knowledge into the
unknown additional steps in intracellular solute, iron and heme trafficking crucial for erythropoiesis. The results
of our proposal will provide us with new genetic tools to explore human disorders of anemias.
项目摘要
该建议的总体目的是识别和表征与红细胞相关的新型蛋白质
铁/血红素代谢。红细胞生成是一种在细胞增殖和合成中的大规模运动
蛋白质,血红蛋白。结果,对铁和血红素有巨大的需求有效
在发展中的Erythron中贩运。尽管我们对细胞外铁的理解取得了进步
贩运和原始孢子蛋白生物合成,仍然存在明显的差距,尤其是在组件方面
涉及铁从内体流出到线粒体,铁/血红素在
线粒体,原始卟啉创世纪所需的转运蛋白,辅助因子促进细胞内的辅助因子
铁/血红素的贩运,以及最终从线粒体中出口血红素,以融入
血红蛋白。使用转录分析的遗传学和生物信息学的互补方法,我们
以前已经确定了几种蛋白质,例如Mitoferrin1(MFRN1),分类Nexin3(SNX3),TMEM14C,LAT3和
Clpx1,作为铁,血红素和营养物质的细胞内运输中的新成分,对红细胞至关重要
发展。尽管所提供的见解,但我们表明了翻译后
机制在与铁和血红素有关的蛋白质的表达和功能中起着同样关键的作用
代谢。使用定量质谱法,我们检查了线粒体蛋白质组的变化
红细胞细胞经历成熟。我们确定了几个溶质载体和跨膜蛋白,它们的蛋白质
先前尚未归因于红细胞蛋白诱导的红细胞生成中的功能。我们
建议研究这7个候选基因的表达和功能丧失表型(AIM 1)。在
特别是,我们计划将以前确定的基因,FAM210B(C20ORF108)及其相互作用的伙伴以红色为重点
细胞开发(AIM 2)。这些结构基因的功能阐明将使我们的知识扩展到
细胞内溶质,铁和血红素运输的其他步骤对促红细胞生成至关重要。结果
我们的建议将为我们提供新的遗传工具来探索贫血的人类疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Yvette Y Yien的其他基金
Regulation of erythroid iron metabolism by the CLPX unfoldase
CLPX 解折叠酶对红细胞铁代谢的调节
- 批准号:1071649410716494
- 财政年份:2023
- 资助金额:$ 33.9万$ 33.9万
- 项目类别:
Regulation of heme synthesis by mitochondrial proteins
线粒体蛋白对血红素合成的调节
- 批准号:1054060410540604
- 财政年份:2019
- 资助金额:$ 33.9万$ 33.9万
- 项目类别:
Regulation of heme synthesis by mitochondrial proteins
线粒体蛋白对血红素合成的调节
- 批准号:1066495010664950
- 财政年份:2019
- 资助金额:$ 33.9万$ 33.9万
- 项目类别:
Regulation of heme synthesis by mitochondrial proteins
线粒体蛋白对血红素合成的调节
- 批准号:1045629510456295
- 财政年份:2019
- 资助金额:$ 33.9万$ 33.9万
- 项目类别:
Regulation of heme synthesis by mitochondrial proteins
线粒体蛋白对血红素合成的调节
- 批准号:1000094110000941
- 财政年份:2019
- 资助金额:$ 33.9万$ 33.9万
- 项目类别:
Regulation of heme synthesis by mitochondrial proteins
线粒体蛋白对血红素合成的调节
- 批准号:1073915110739151
- 财政年份:2019
- 资助金额:$ 33.9万$ 33.9万
- 项目类别:
Mechanism and Function of TMEM14 proteins in vertebrate heme synthesis
TMEM14蛋白在脊椎动物血红素合成中的机制和功能
- 批准号:97512819751281
- 财政年份:2015
- 资助金额:$ 33.9万$ 33.9万
- 项目类别:
Regulation of mitochondrial heme metabolism by Tmem14c
Tmem14c 对线粒体血红素代谢的调节
- 批准号:86775788677578
- 财政年份:2013
- 资助金额:$ 33.9万$ 33.9万
- 项目类别:
Regulation of mitochondrial heme metabolism by Tmem14c
Tmem14c 对线粒体血红素代谢的调节
- 批准号:85255158525515
- 财政年份:2013
- 资助金额:$ 33.9万$ 33.9万
- 项目类别:
相似国自然基金
32P-可降解微球调控TAM-FABP1细胞群的脂质代谢对肝细胞癌免疫微环境的影响及机制
- 批准号:82372065
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
冷泉硫酸盐还原菌碳硫代谢影响微生物群落演替的作用机制
- 批准号:42306171
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
儿童脂肪、肌肉构成及相互作用对心血管代谢异常发生风险的影响及机制研究
- 批准号:82373589
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
DJ-1通过影响UCP1稳定性调控机体代谢稳态的机制研究
- 批准号:32371194
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
桑叶多糖与肠道菌群互作产物通过影响肝miRNA调控脂代谢的作用机制研究
- 批准号:32372245
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:1075255510752555
- 财政年份:2024
- 资助金额:$ 33.9万$ 33.9万
- 项目类别:
Maternal immune activation remodeling of offspring glycosaminoglycan sulfation patterns during neurodevelopment
神经发育过程中后代糖胺聚糖硫酸化模式的母体免疫激活重塑
- 批准号:1050830510508305
- 财政年份:2023
- 资助金额:$ 33.9万$ 33.9万
- 项目类别:
Center of Research Translation on Osteoporosis Bone Anabolic Therapies
骨质疏松症骨合成代谢疗法研究转化中心
- 批准号:1040441210404412
- 财政年份:2023
- 资助金额:$ 33.9万$ 33.9万
- 项目类别:
Regulation of CSE-Derived Hydrogen Sulfide in the Heart
CSE 衍生的硫化氢在心脏中的调节
- 批准号:1065983210659832
- 财政年份:2023
- 资助金额:$ 33.9万$ 33.9万
- 项目类别:
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
- 批准号:1076104410761044
- 财政年份:2023
- 资助金额:$ 33.9万$ 33.9万
- 项目类别: